In this COVID-19 clinical update, Daniel Griffin summarizes current status of vaccination in the US, discusses a study on convalescent sera from Argentina, use of remdesivir in patients with kidney disease, and provides further considerations on the use of Ct values in patient management.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Argentine study on plasma therapy (NEJM)
• Ct values and clinical outcome (Open Forum Inf Dis)
• Bamlanivimab fact sheet (FDA pdf)
• Cognitive defects in recovered COVID-19 patients (medRxiv)
• Letters read on TWiV 704
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]